evidence: Bern, 26.11.2021 - In view of the significant rise in cases in Switzerland, the Federal Office of Public Health FOPH and the Federal Commission for Vaccination (FCV) recommend a booster vaccination for the general population, including for under-65s. This is in line with the authorisation decision taken by Swissmedic, the Agency for Therapeutic Products. The booster vaccination is intended to strengthen individual protection against infection and slow down the transmission and spread of the virus in the current epidemiological situation. So far, more than 350,000 people have received a booster vaccination. These are over-65s and younger persons who are at the highest risk of experiencing serious illness. These groups will continue to have priority access to a booster vaccination. [...] In the current epidemic situation, the FOPH and FCV recommendation that all young people aged 16 and over and all adults should receive a booster vaccination is also aimed at helping prevent the healthcare system from becoming overloaded. The recommendation is based on Swissmedic’s authorisation extension. This permits a booster vaccination with the two mRNA vaccines, using Pfizer for people aged over 16 and Moderna for those aged over 18. [...] Switzerland has sufficient vaccine of both mRNA products to offer vaccinations in 2021 and 2022 to all those recommended for a booster vaccination and to all those who have not yet been vaccinated.